Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 


Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Feb 13, 2023

Dr. Joslyn Kirby is the President of the HS Foundation, which focuses on improving the lives of those who suffer from Hidradenitis Suppurativa, a skin condition caused by an overactive immune system. Generally people with this condition are misdiagnosed with skin infections and treated with ineffective antibiotics. As a member of the DermTech Scientific Board, Joslyn sees the promise of this non-invasive technology to make a diagnosis for someone with the disease or help make a precise therapeutic selection.

 Joslyn explains, "This condition is not new. It's just that we've gotten better at giving it a name. It's gotten a lot more attention, which it deserves because it's so devastating to some patients but mildly annoying to others. Still, either way, it's impactful to people's quality of life. So being able to find it is number one. Number two, give it a name. And then, number three, really pursue treatments that are going to be more effective than just antibiotic courses now and again."

"The nice thing about the DermTech technology is that it is non-invasive, and people with HS are already going through so much discomfort because of the inflammation of this condition. I really like a technology like this where I can promise them I don't have to hurt you to help you, but to be able to get clues from what's happening in the skin cells to help. We can either make the diagnosis for somebody who's been struggling or, to help make a therapeutic selection, to take an injection that deals with one part of the immune system rather than a pill that might affect a different part of the immune system. To be able to look at what is happening within these cells at a molecular level, I think, would really help both patients and physicians. So I'm looking forward to what we can do with this technology."

 @HSOrg #HSFoundation #HidradenitisSuppurativa #HS #DermTechStratum #SmartSticker #PrecisionMedicine #PrecisionDermatology

Download the transcript here

HS Foundation